Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis

H. Kamiya (Perth, Australia), O. Panlaqui (Richmond, Australia)

Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Session: Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Session type: Thematic Poster
Number: 2949
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Kamiya (Perth, Australia), O. Panlaqui (Richmond, Australia). Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. 2949

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Source: Eur Respir J 2015; 46: 1113-1130
Year: 2015



The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

A systematic review and individual participant data meta-analysis of MMP-7 and outcomes in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Association between FVC and mortality or survival in idiopathic pulmonary fibrosis: a systematic literature review
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019
Year: 2020



Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020
Year: 2021



Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Source: Eur Respir J 2015; 46: 795-806
Year: 2015



Pulmonary hypertension in COPD patients: a systematic review and meta-analysis
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


Surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis: a systematic review
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

Systematic review of content and quality of idiopathic pulmonary fibrosis review articles
Source: ERJ Open Res, 4 (4) 00156-2018; 10.1183/23120541.00156-2018
Year: 2018



A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 26 (144) 160125; 10.1183/16000617.0125-2016
Year: 2017



Gender and racial equity in clinical research for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Source: Eur Respir J, 59 (3) 2102969; 10.1183/13993003.02969-2021
Year: 2022



The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies
Source: Eur Respir J, 51 (6) 1800376; 10.1183/13993003.00376-2018
Year: 2018



Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

A systematic review of prognostic models in COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Prognostic evaluation in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Prevalence of COPD by severity level: systematic review and meta-analysis
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007


Prognostic significance of right heart thrombi (RHT) in patients with acute symptomatic pulmonary embolism: Systematic review and meta-analysis
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016